Fifth Third Bancorp
BBIO icon

Fifth Third Bancorp’s BridgeBio Pharma BBIO Stock Holding History

Fifth Third Bancorp’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.69M Buy
+49,729
New +$3.6M 0.01% 902
2025
Q4 		– Sell
-30
Closed -$1.56K – 2643
2025
Q3 		$1.56K Buy
+30
New +$1.46K ﹤0.01% 2481
2021
Q2 		– Sell
-100
Closed -$6K – 2423
2021
Q1 		$6K Buy
+100
New +$6.54K ﹤0.01% 2131

Other funds holding BBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fifth Third Bancorp's BBIO Position: Q1 2026 in Review

Fifth Third Bancorp opened a new position in BridgeBio Pharma (BBIO) in Q1 2026: 49,729 shares worth $3.69M. The stake represents 0.01% of the portfolio and ranks #902 among its holdings. This is a return to the name: Fifth Third Bancorp previously reported a position in BBIO as recently as Q3 2025.

Fifth Third Bancorp first reported a position in BBIO in Q1 2021 and has held it in 3 quarters since. 457 funds tracked by Wall St. Rank hold BBIO as of Q1 2026.

  • Fifth Third Bancorp held 49,729 shares of BridgeBio Pharma worth $3.69M as of Q1 2026.
  • BridgeBio Pharma was a new Fifth Third Bancorp position in Q1 2026.
  • BridgeBio Pharma made up 0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #902 holding.
  • Fifth Third Bancorp first reported a position in BridgeBio Pharma in Q1 2021 and has held it in 3 quarters since.
  • 457 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.